These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12028603)

  • 1. Innovative drug treatments for viral and autoimmune myocarditis.
    Frishman WH; O'Brien M; Naseer N; Anandasabapathy S
    Heart Dis; 2002; 4(3):171-83. PubMed ID: 12028603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innovative drug treatments for viral and autoimmune myocarditis.
    Anandasabapathy S; Frishman WH
    J Clin Pharmacol; 1998 Apr; 38(4):295-308. PubMed ID: 9590456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and management of viral myocarditis.
    Frishman WH; Zeidner J; Naseer N
    Curr Treat Options Cardiovasc Med; 2007 Dec; 9(6):450-64. PubMed ID: 18221597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition and optimum management of myocarditis.
    Caforio AL; McKenna WJ
    Drugs; 1996 Oct; 52(4):515-25. PubMed ID: 8891464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of dilated cardiomyopathies with and without inflammation].
    Hufnagel G; Pankuweit S; Maisch B
    Med Klin (Munich); 1998 Apr; 93(4):240-51. PubMed ID: 9594534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins.
    Maisch B; Hufnagel G; Kölsch S; Funck R; Richter A; Rupp H; Herzum M; Pankuweit S
    Herz; 2004 Sep; 29(6):624-36. PubMed ID: 15912438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunosuppressive therapy in myocarditis and dilated cardiomyopathy?].
    Schultheiss HP
    Internist (Berl); 1992 Oct; 33(10):650-62. PubMed ID: 1428684
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of OKT3 for acute myocarditis in infants and children.
    Ahdoot J; Galindo A; Alejos JC; George B; Burch C; Marelli D; Sadeghi A; Laks H
    J Heart Lung Transplant; 2000 Nov; 19(11):1118-21. PubMed ID: 11077231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons from animal experiments in myocarditis.
    Matsumori A
    Herz; 1992 Apr; 17(2):107-11. PubMed ID: 1349548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Peculiarities of cardiac failure treatment in diffuse myocarditis and dilated cardiomyopathy].
    Gurevich MA; Iankovskaia MO; Gordienko BV; Mravian SR; Grigor'eva NM
    Klin Med (Mosk); 1997; 75(1):48-50. PubMed ID: 9082062
    [No Abstract]   [Full Text] [Related]  

  • 11. The Myocarditis Treatment Trial: design, methods and patients enrollment.
    Hahn EA; Hartz VL; Moon TE; O'Connell JB; Herskowitz A; McManus BM; Mason JW
    Eur Heart J; 1995 Dec; 16 Suppl O():162-7. PubMed ID: 8682088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive treatment for myocarditis and dilated cardiomyopathy.
    Maisch B; Herzum M; Hufnagel G; Bethge C; Schönian U
    Eur Heart J; 1995 Dec; 16 Suppl O():153-61. PubMed ID: 8682087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global biventricular dysfunction in patients with asymptomatic coronary artery disease may be caused by myocarditis.
    Frustaci A; Chimenti C; Maseri A
    Circulation; 1999 Mar; 99(10):1295-9. PubMed ID: 10077512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapies to limit myocardial injury in animal models of myocarditis: a systematic review and meta-analysis.
    Silverblatt JA; Ziff OJ; Dancy L; Daniel A; Carter B; Scott P; Sado DM; Shah A; Bromage DI
    Basic Res Cardiol; 2019 Oct; 114(6):48. PubMed ID: 31673885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future.
    Kawai C
    Circulation; 1999 Mar; 99(8):1091-100. PubMed ID: 10051305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists in experimental myocarditis.
    Godsel LM; Leon JS; Engman DM
    Curr Pharm Des; 2003; 9(9):723-35. PubMed ID: 12570790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paediatric dilated cardiomyopathy: clinical profile and outcome. The experience of a tertiary centre for paediatric cardiology.
    Miranda JO; Costa L; Rodrigues E; Teles EL; Baptista MJ; Areias JC
    Cardiol Young; 2015 Feb; 25(2):333-7. PubMed ID: 24423967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.
    Psaty BM; Lumley T; Furberg CD; Schellenbaum G; Pahor M; Alderman MH; Weiss NS
    JAMA; 2003 May; 289(19):2534-44. PubMed ID: 12759325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical management of mild-to-moderate heart failure before the advent of beta blockers.
    Abraham WT; Wagoner LE
    Am J Med; 2001 May; 110 Suppl 7A():47S-62S. PubMed ID: 11334776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel therapeutic options in inflammatory cardiomyopathy.
    Kania G; Blyszczuk P; Müller-Edenborn B; Eriksson U
    Swiss Med Wkly; 2013; 143():w13841. PubMed ID: 23986269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.